Longboard Pharmaceuticals Price on October 5, 2023
| LBPHDelisted Stock | USD 59.98 0.00 0.00% |
If you're considering investing in Longboard Stock, it is important to understand the factors that can impact its price. As of today, the current price of Longboard Pharmaceuticals stands at 59.98, as last reported on the 22nd of December, with the highest price reaching 59.98 and the lowest price hitting 59.98 during the day. Longboard Pharmaceuticals is not too volatile given 3 months investment horizon. Longboard Pharmaceuticals has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 1.39% are justified by taking the suggested risk. Use Longboard Pharmaceuticals Risk Adjusted Performance of 0.1149, mean deviation of 3.24, and Downside Deviation of 4.01 to evaluate company specific risk that cannot be diversified away.
Longboard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Longboard |
Sharpe Ratio = 0.181
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | LBPH | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.66 actual daily | 68 68% of assets are less volatile |
Expected Return
| 1.39 actual daily | 27 73% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Longboard Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Longboard Pharmaceuticals by adding it to a well-diversified portfolio.
Longboard Pharmaceuticals Valuation on October 5, 2023
It is possible to determine the worth of Longboard Pharmaceuticals on a given historical date. On October 5, 2023 Longboard was worth 4.68 at the beginning of the trading date compared to the closed value of 5.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Longboard Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Longboard Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Longboard Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Longboard Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 4.80 | 4.80 | 4.34 | 4.58 | 56,700 | |
10/05/2023 | 4.68 | 5.15 | 4.54 | 5.02 | 62,400 |
| 4.84 | 5.42 | 4.84 | 5.30 | 23,400 |
| Backtest Longboard Pharmaceuticals | | | Longboard Pharmaceuticals History | | | Longboard Pharmaceuticals Valuation | Previous | Next |
Longboard Pharmaceuticals Trading Date Momentum on October 5, 2023
| On October 06 2023 Longboard Pharmaceuticals was traded for 5.30 at the closing time. The top price for the day was 5.42 and the lowest listed price was 4.84 . The trading volume for the day was 23.4 K. The trading history from October 6, 2023 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 5.58% . The trading delta at closing time against the current closing price is 0.60% . |
Longboard Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Longboard Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Longboard Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Longboard financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Longboard Pharmaceuticals Stock history
Longboard Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Longboard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Longboard Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Longboard Pharmaceuticals stock prices may prove useful in developing a viable investing in Longboard Pharmaceuticals
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.
Longboard Pharmaceuticals Stock Technical Analysis
Longboard Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Longboard Pharmaceuticals Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Longboard Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Longboard Pharmaceuticals December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Longboard Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Longboard Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Longboard Pharmaceuticals stock market strength indicators, traders can identify Longboard Pharmaceuticals entry and exit signals to maximize returns
Longboard Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Longboard Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Longboard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Longboard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1149 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 0.7775 | |||
| Sortino Ratio | 0.2401 | |||
| Treynor Ratio | (0.75) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |